हिंदी में पढ़ें

Biocon

Should you buy, sell or hold L&T, Tata Power, Biocon, other stocks now?

Should you buy, sell or hold L&T, Tata Power, Biocon, other stocks now?

Thu, Oct 31, 2024

Share Market News: Here's how brokerages view a bunch of stocks today, including Larsen & Toubro, Tata Power and Biocon.

Biocon gets 4 observations from USFDA for Bengaluru API facility

Biocon gets 4 observations from USFDA for Bengaluru API facility

Sat, Sep 28, 2024

The US Food and Drug Administration (USFDA) conducted a surveillance inspection of the API facility (Site 2), located at Bengaluru from September 23- 27, 2024.

LIC raises stake in Biocon to 5.02%

LIC raises stake in Biocon to 5.02%

Wed, Sep 18, 2024

The company has increased its shareholding in equity shares of Biocon Ltd to 5.023 per cent.

TRENDING NOW

Axis Direct picks JSW Steel, Balrampur Chini, Biocon and 2 other stocks for 15 days; check out targets and stop losses

Axis Direct picks JSW Steel, Balrampur Chini, Biocon and 2 other stocks for 15 days; check out targets and stop losses

Mon, Sep 16, 2024

Axis Direct has given a 'buy' rating on Balrampur Chini. The brokerage has given a target of Rs 638 and a stop loss of Rs 560. This means the stock has an upside of 12 per cent from its last closing price.

Stock of The Day: Today Anil Singhvi gave the opinion of buying in Eicher Motor, ABB and selling in SAIL and BIOCON

Stock of The Day: Today Anil Singhvi gave the opinion of buying in Eicher Motor, ABB and selling in SAIL and BIOCON

Fri, Aug 09, 2024

Stock of The Day: Today Anil Singhvi gave the opinion of buying in Eicher Motor, ABB and selling in SAIL and BIOCON. What are stoploss and targets? See in this video.

Which stocks will be in focus today including Eicher Motors, ABB India, Biocon and SAIL?

Which stocks will be in focus today including Eicher Motors, ABB India, Biocon and SAIL?

Fri, Aug 09, 2024

Which stocks will be in focus today including Eicher Motors, ABB India, Biocon and SAIL? On the basis of which news there will be action in the market? What are the important triggers for the market? Know here.

Biocon Biologics got approval from the European Medicines Agency to manufacture biosimilar Bevacizumab in India

Biocon Biologics got approval from the European Medicines Agency to manufacture biosimilar Bevacizumab in India

Mon, Jun 24, 2024

Biocon Biologics, a subsidiary of Biocon, on Monday got approval from the European Medicines Agency (EMA) to manufacture biosimilar Bevacizumab in India.

Biocon gets 4 observations from USFDA for Andhra Pradesh facility

Biocon gets 4 observations from USFDA for Andhra Pradesh facility

Sat, Jun 22, 2024

The US Food and Drug Administration (USFDA) concluded a GMP inspection of the company's API facility (Site 5), located at Visakhapatnam, Andhra Pradesh, on June 21, 2024, the company said in a regulatory filing.

Biocon Q4 results: Net profit falls 57% to Rs 136 crore; revenue at Rs 3,966 crore

Biocon Q4 results: Net profit falls 57% to Rs 136 crore; revenue at Rs 3,966 crore

Thu, May 16, 2024

The company posted a net profit of Rs 313 crore in the January-March quarter of the last fiscal. Total revenue rose marginally to Rs 3,966 crore in the fourth quarter compared with Rs 3,929 crore in the year-ago period, Biocon said in a statement.

Biocon partners Biomm to commercialise diabetes drug in Brazil

Biocon partners Biomm to commercialise diabetes drug in Brazil

Wed, Apr 17, 2024

Biomm focuses on developing, manufacturing and commercialising complex biotech and biosimilar drug products at its production facility in Nova Lima.

Biocon shares jump as unit signs long-term deal with Eris Lifesciences

Biocon shares jump as unit signs long-term deal with Eris Lifesciences

Thu, Mar 14, 2024

Biocon shares extended their intraday gains in late afternoon deals on Thursday after the biopharmaceuticals firm said its subsidiary, Biocon Biologics, had entered into a long-term commercial collaboration deal with Eris Lifesciences.

Unlocking Opportunities: Biocon, Aarti Industries, Zomato - What's the Right Move After Results?

Unlocking Opportunities: Biocon, Aarti Industries, Zomato - What's the Right Move After Results?

Fri, Feb 09, 2024

Should you sell Biocon after the results? Aarti Industries' results are weak, but should you buy the stock? HOLD Zomato as investment after excellent results? Know the analysis on the results from Anil Singhvi...

Biocon shares slip over 4.5% after Q3 results, partnership with Sandoz

Biocon shares slip over 4.5% after Q3 results, partnership with Sandoz

Fri, Feb 09, 2024

Biocon share price: The company on Thursday reported a consolidated net profit of Rs 660 crore for the third quarter ended December 31, 2023, on the back of robust sales. It reported a net loss of Rs 42 crore in the October-December period of the last fiscal.

Biocon Q3 results: Company posts net profit at Rs 660 crore

Biocon Q3 results: Company posts net profit at Rs 660 crore

Thu, Feb 08, 2024

"A key milestone this quarter was the successful conclusion of the transition of the acquired business by Biocon Biologics and a pre-payment of USD 200 million towards the acquisition-related debt reduction," Biocon Executive Chairperson Kiran Mazumdar Shaw said.

Biocon Q3 preview: Firm likely to post profit of Rs 192 crore against a loss in Q3 FY23

Biocon Q3 preview: Firm likely to post profit of Rs 192 crore against a loss in Q3 FY23

Thu, Feb 08, 2024

EBITDA, or earnings before interest, taxes, depreciation, and amortisation, is also set to log a double-digit increase of 29 per cent in Q3 to Rs 830 crore as against Rs 646 crore logged in Q3 FY23.

Biocon jumps after inking deal with Sandos for distribution of FKB injection in Japan

Biocon jumps after inking deal with Sandos for distribution of FKB injection in Japan

Tue, Dec 26, 2023

Biocon Biologics has acquired the global biosimilars portfolio of Viatris including Adalimumab. Fujifilm Kyowa Kirin Biologics Co. Ltd., the developer of the drug, has concluded an exclusive global marketing license agreement with Biocon Biologics Ltd affiliate.

Biocon's subsidiary completes integration of Viatris’ biosimilars business; stock rises

Biocon's subsidiary completes integration of Viatris’ biosimilars business; stock rises

Fri, Dec 01, 2023

Biocon share price: At around 10:42 a.m., Biocon shares were up 1.51 per cent, or Rs 3.6, at Rs 242.05 apiece on BSE. The market capitalisation of the company stood at Rs 29,060.52 crore at around the same time.

Biocon Q2 nos miss estimates; brokerages cut targets; stock slips

Biocon Q2 nos miss estimates; brokerages cut targets; stock slips

Mon, Nov 13, 2023

At around 9:50 a.m., shares of Biocon traded 3.85 per cent, or Rs 9.05 lower, at Rs 225.75 apiece. The market capitalisation of the company stood at Rs 27,169.58 crore.

Biocon Q2 Results Preview: Biocon likely to bank on Viatris acquisition; sales, margin may soar considerably

Biocon Q2 Results Preview: Biocon likely to bank on Viatris acquisition; sales, margin may soar considerably

Wed, Nov 08, 2023

Biocon Q2 Results Preview: Biocon's biologics sales are set to double, while margin can also improve considerably due to the integration of American pharma firm Viatris, as the Bengaluru-based pharma company is set to announce its July-September quarter results on Friday (Novembe

Syngene shares plunge after contract research firm trims revenue guidance

Syngene shares plunge after contract research firm trims revenue guidance

Wed, Oct 18, 2023

Syngene International trimmed its revenue growth guidance to mid-teen levels in constant currency terms for the six-month period ending March 2024, sending its shares tumbling.

Biocon tanks after subsidiary vows correction action at Malaysia facility

Biocon tanks after subsidiary vows correction action at Malaysia facility

Wed, Oct 18, 2023

At 11:20 am, Biocon shares were down 4.48 per cent at Rs 243 apiece on BSE.

Biocon Q1 result: Net profit falls 11% to Rs 148.9 crore

Biocon Q1 result: Net profit falls 11% to Rs 148.9 crore

Thu, Aug 10, 2023

Biocon Ltd on Thursday reported an 11 per cent decline in consolidated net profit at Rs 148.9 crore in the first quarter ended June 30, 2023.

Biocon shares rose after USFDA issues 'no observations' on Bengaluru facility

Biocon shares rose after USFDA issues 'no observations' on Bengaluru facility

Mon, Jun 05, 2023

Biocon shares on June 5 edged higher on the back of the USFDA issuing 'no observations' on the company's oral solid dosage formulations manufacturing facility at Bengaluru.

Load More

LIVE TV

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x